STABILISATION MEASURES TAKEN

NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

This announcement does not constitute an offering circular and nothing herein contains an offering of securities.

With reference to the company announcement no. 7/2017 dated 16 November 2017 regarding the beginning of the stabilisation period following the initial public offering and admission to trading and official listing of the temporary purchase certificates and the shares of Orphazyme A/S ("Orphazyme") on Nasdaq Copenhagen (the "Offering" or the "IPO"), Orphazyme has received notification that Danske Bank, acting as stabilising manager in the Offering, has taken stabilisation measures between 27 November 2017 and 5 December 2017 as set out in the attached notification with respect to the shares of Orphazyme.

https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=3411225&lang=en-GB&companycode=dk-orpha&v=

 

For additional information, please contact

Orphazyme 

Anders Hinsby, CEO+45 31 44 31 39

Impact Partners  

Michael Steen-Knudsen+45 25 17 18 15